Europe Pharmaceutical Excipients Market Size is USD 3.23 Billion in 2026
Europe Pharmaceutical Excipients Market (By Product: Organic Chemicals, Inorganic Chemicals; By Functionality: Fillers & Diluents, Binders, Suspension and Viscosity Agents, Coatings (Film & Enteric), Flavoring Agents, Disintegrants, Colorants, Preservatives, Other Functionalities; By Formulation: Oral Solid Dosage Forms, Parenteral Formulations, Topical & Transdermal, Pulmonary/Inhalation, Ophthalmic, Others (Sublingual, Buccal, etc.); By Source: Plant-based, Animal-based, Synthetic, Mineral-based, Marine-based.By Product: Organic Chemicals, Inorganic Chemicals; By Functionality: Fillers & Diluents, Binders, Suspension and Viscosity Agents, Coatings (Film & Enteric), Flavoring Agents, Disintegrants, Colorants, Preservatives, Other Functionalities; By Formulation: Oral Solid Dosage Forms, Parenteral Formulations, Topical & Transdermal, Pulmonary/Inhalation, Ophthalmic, Others (Sublingual, Buccal, etc.); By Source: Plant-based, Animal-based, Synthetic, Mineral-based, Marine-based) Industry Size, Share, Growth, Trends 2025 to 2035
The Europe pharmaceutical excipients market size accounted for USD 3.01 billion in 2025 and is predicted to touch around USD 6.09 billion by 2035, growing at a CAGR of 7.3% from 2026 to 2035. The rising number of controlled-release medications is increasing demand for the specialized excipients. The growing critical formulation challenges are bringing out the core potency of the novel excipients.
Europe Pharmaceutical Excipients Market Statical Scope
| Reports Attributes | Statistics |
| Market Size in 2025 | USD 3.01 Billion |
| Market Size in 2026 | USD 3.23 Billion |
| Market Size by 2035 | USD 6.09 Billion |
| CAGR 2026 to 2035 | 7.3% |
| Base Year | 2025 |
| Forecast Period | 2026 to 2035 |
The green excipients are unveiling the proficiency of the plant-derived materials, spurring sustainable value in the regional market. While the fillers and binders are encouraging more supply and demand for the capsules and tablets in the healthcare sector. The healthcare businesses are aligned with each of the major factors connected to the regulatory terms, and so the safe excipients are in traction.
Europe Pharmaceutical Excipients Market Share, By Product, 2025 (%)
| Segments | Shares (%) |
| Organic Chemicals | 68% |
| Inorganic Chemicals | 32% |
- Organic Chemicals – The organic chemicals segment dominated the market by 68% of share, with impressive innovations and attractive investments in the R&D sector. The organic ingredients act as a fuel for the segmental growth.
- Inorganic Chemicals – The inorganic chemicals held 32% of the share due to the powerful high-end manufacturing encouraging the production to practice transitions and bring major shifts in the materials to achieve efficacy and double purity.
Europe Pharmaceutical Excipients Market Share, By Functionality, 2025 (%)
| Segments | Shares (%) |
| Fillers and Diluents | 28% |
| Binders | 15% |
| Coatings (Film & Enteric) | 12% |
| Disintegrants | 11% |
| Suspension & Viscosity Agents | 10% |
| Other Functionalities | 9% |
| Flavoring Agents | 6% |
| Colorants | 5% |
| Preservatives | 4% |
- Fillers and Diluents – The segment leads by 28% of share as the valuable alternative to natural essence to the market is accelerating the role of this functionality. The capsule and tablet formulation promotes the segmental value in the market.
- Binders – The binders acquires 15% of the share as the starch-based binders are in form due to their effectiveness. The solid dosages segment is bringing great profit to the segmental market and presence in the healthcare sector.
- Coatings (Film and Enteric) – The segment covers 12% of the share, as the growing requirement for pH-responsive drug release and gastric protection is paving the way for opportunities in the segmental market.
- Suspension and Viscosity Agents – The segment leads by 10% of share as the dominance of multifunctional excipients that unlock more scope for the segment to prove its capacity. The oral suspension is in a form serving precision dosing.
Europe Pharmaceutical Excipients Market Share, By Formulation, 2025 (%)
| Segments | Shares (%) |
| Oral Solid Dosage Forms | 52% |
| Parenteral Formulations | 18% |
| Topical & Transdermal | 11% |
| Others (Sublingual, Buccal) | 8% |
| Pulmonary/Inhalation | 6% |
| Ophthalmic | 5% |
- Oral Solid Dosage Forms – The segment acquires 52% of profit with the popular use of co-processed excipients for quick compression. The improvement in stability and precision in patient-centric formulations describes the power of the segment in the market.
- Parenteral Formulations – The parenteral formulations covers 18% of the share as the advanced treatments and home care trend is heading towards valuable contribution for the segmental market. This stimulates demand for easy and well-balanced formulations.
- Topical and Transdermal – The segment leads by 11% of share with the popular transitions in the home care trend, confirming profit for the segmental market. The common treatments and non-invasive drug delivery are accelerating the growth of the segmental market.
- Pulmonary/Inhalation – The segment acquires 6% of the share with the involvement of robust formulation technologies featuring the value and expansion of modern excipients. The transition in the dual excipient platforms doubles the success for the segment.
Europe Pharmaceutical Excipients Market Share, By Source, 2025 (%)
| Segments | Shares (%) |
| Plant-based | 36% |
| Synthetic | 30% |
| Animal-based | 18% |
| Mineral-based | 16% |
- Plant-based – The plant-based segment held 36% of share as its a safe alternative, keeping the ecosystems green health at the heart of the market. The famous vegan trend is a reason for the hype in the market segment.
- Synthetic – The synthetic segment covers 30% of the share as the rising craze of biosimilars and modern drug delivery systems is confirming the need and effective impact of the segmental market. Its best in-class source for the organic alternatives.
- Animal-based – The animal-based segment leads by 18% of share, featuring excellent performance of lactose, gelatin, lanolin, beeswax, and stearic acid, which describes the strength of the segment. The veterinary API manufacturing is a main customer of the segmental market.
- Mineral-based – The segment covers 16% of the share as the impressive innovations in the functional minerals are attracting investments for co-processed excipients that introduce a robust merger of the mineral materials.
Top Companies in the Europe Pharmaceutical Excipients Market
- BASF SE
- Ashland Global Holdings Inc.
- DuPont de Nemours Inc.
- Roquette Frères SA
- Evonik Industries AG
- Archer Daniels Midland Co.
- Kerry Group plc
- The Lubrizol Corporation
- Air Liquide SA
- Croda International plc
- Innophos Holdings Inc.
- Colorcon Inc.
- DFE Pharma GmbH & Co. KG
- JRS Pharma GmbH & Co. KG
- Eastman Chemical Company
- International Flavors & Fragrances Inc.
- Merck KGaA
- Dow Inc.
- Gattefossé SA
- Shin-Etsu Chemical Co. Ltd.
Segments Covered in the Report
By Product
- Organic Chemicals
- Inorganic Chemicals
By Functionality
- Fillers & Diluents
- Binders
- Suspension and Viscosity Agents
- Coatings (Film & Enteric)
- Flavoring Agents
- Disintegrants
- Colorants
- Preservatives
- Other Functionalities
By Formulation
- Oral Solid Dosage Forms
- Parenteral Formulations
- Topical & Transdermal
- Pulmonary/Inhalation
- Ophthalmic
- Others (Sublingual, Buccal, etc.)
By Source
- Plant-based
- Animal-based
- Synthetic
- Mineral-based
- Marine-based
List of Tables & Figures
List of Tables
Table 1: Europe Pharmaceutical Excipients Market Size, By Product, 2025-2035 (USD Billion)
Table 2: Europe Pharmaceutical Excipients Market Size, By Functionality, 2025-2035 (USD Billion)
Table 3: Europe Pharmaceutical Excipients Market Size, By Formulation, 2025-2035 (USD Billion)
Table 4: Europe Pharmaceutical Excipients Market Size, By Source, 2025-2035 (USD Billion)
Table 5: Europe Pharmaceutical Excipients Market Size, By Country, 2025-2035 (USD Billion)
Table 6: Europe Organic Chemicals Excipients Market Size, 2025-2035 (USD Billion)
Table 7: Europe Inorganic Chemicals Excipients Market Size, 2025-2035 (USD Billion)
Table 8: Europe Fillers & Diluents Excipients Market Size, 2025-2035 (USD Billion)
Table 9: Europe Binders Excipients Market Size, 2025-2035 (USD Billion)
Table 10: Europe Suspension & Viscosity Agents Excipients Market Size, 2025-2035 (USD Billion)
Table 11: Europe Coatings (Film & Enteric) Excipients Market Size, 2025-2035 (USD Billion)
Table 12: Europe Flavoring Agents Excipients Market Size, 2025-2035 (USD Billion)
Table 13: Europe Disintegrants Excipients Market Size, 2025-2035 (USD Billion)
Table 14: Europe Colorants Excipients Market Size, 2025-2035 (USD Billion)
Table 15: Europe Preservatives Excipients Market Size, 2025-2035 (USD Billion)
Table 16: Europe Other Functionalities Excipients Market Size, 2025-2035 (USD Billion)
Table 17: Europe Oral Solid Dosage Forms Excipients Market Size, 2025-2035 (USD Billion)
Table 18: Europe Parenteral Formulations Excipients Market Size, 2025-2035 (USD Billion)
Table 19: Europe Topical & Transdermal Excipients Market Size, 2025-2035 (USD Billion)
Table 20: Europe Pulmonary/Inhalation Excipients Market Size, 2025-2035 (USD Billion)
Table 21: Europe Ophthalmic Excipients Market Size, 2025-2035 (USD Billion)
Table 22: Europe Others (Sublingual, Buccal, etc.) Excipients Market Size, 2025-2035 (USD Billion)
Table 23: Europe Plant-based Excipients Market Size, 2025-2035 (USD Billion)
Table 24: Europe Animal-based Excipients Market Size, 2025-2035 (USD Billion)
Table 25: Europe Synthetic Excipients Market Size, 2025-2035 (USD Billion)
Table 26: Europe Mineral-based Excipients Market Size, 2025-2035 (USD Billion)
Table 27: Europe Marine-based Excipients Market Size, 2025-2035 (USD Billion)
Table 28: Germany Pharmaceutical Excipients Market Size, 2025-2035 (USD Billion)
Table 29: France Pharmaceutical Excipients Market Size, 2025-2035 (USD Billion)
Table 30: UK Pharmaceutical Excipients Market Size, 2025-2035 (USD Billion)
Table 31: Italy Pharmaceutical Excipients Market Size, 2025-2035 (USD Billion)
Table 32: Spain Pharmaceutical Excipients Market Size, 2025-2035 (USD Billion)
Table 33: Rest of Europe Pharmaceutical Excipients Market Size, 2025-2035 (USD Billion)
List of Figures
Figure 1: Europe Pharmaceutical Excipients Market Share, By Product, 2025 (%)
Figure 2: Europe Pharmaceutical Excipients Market Share, By Functionality, 2025 (%)
Figure 3: Europe Pharmaceutical Excipients Market Share, By Formulation, 2025 (%)
Figure 4: Europe Pharmaceutical Excipients Market Share, By Source, 2025 (%)
Figure 5: Europe Pharmaceutical Excipients Market Share, By Country, 2025 (%)
Figure 6: Europe Pharmaceutical Excipients Market Forecast, 2025-2035 (USD Billion)
Figure 7: Organic Chemicals Excipients Market Forecast, 2025-2035 (USD Billion)
Figure 8: Inorganic Chemicals Excipients Market Forecast, 2025-2035 (USD Billion)
Figure 9: Fillers & Diluents Excipients Market Forecast, 2025-2035 (USD Billion)
Figure 10: Binders Excipients Market Forecast, 2025-2035 (USD Billion)
Figure 11: Suspension & Viscosity Agents Excipients Market Forecast, 2025-2035 (USD Billion)
Figure 12: Coatings (Film & Enteric) Excipients Market Forecast, 2025-2035 (USD Billion)
Figure 13: Flavoring Agents Excipients Market Forecast, 2025-2035 (USD Billion)
Figure 14: Disintegrants Excipients Market Forecast, 2025-2035 (USD Billion)
Figure 15: Colorants Excipients Market Forecast, 2025-2035 (USD Billion)
Figure 16: Preservatives Excipients Market Forecast, 2025-2035 (USD Billion)
Figure 17: Other Functionalities Excipients Market Forecast, 2025-2035 (USD Billion)
Figure 18: Oral Solid Dosage Forms Excipients Market Forecast, 2025-2035 (USD Billion)
Figure 19: Parenteral Formulations Excipients Market Forecast, 2025-2035 (USD Billion)
Figure 20: Topical & Transdermal Excipients Market Forecast, 2025-2035 (USD Billion)
Figure 21: Pulmonary/Inhalation Excipients Market Forecast, 2025-2035 (USD Billion)
Figure 22: Ophthalmic Excipients Market Forecast, 2025-2035 (USD Billion)
Figure 23: Others (Sublingual, Buccal, etc.) Excipients Market Forecast, 2025-2035 (USD Billion)
Figure 24: Plant-based Excipients Market Forecast, 2025-2035 (USD Billion)
Figure 25: Animal-based Excipients Market Forecast, 2025-2035 (USD Billion)
Figure 26: Synthetic Excipients Market Forecast, 2025-2035 (USD Billion)
Figure 27: Mineral-based Excipients Market Forecast, 2025-2035 (USD Billion)
Figure 28: Marine-based Excipients Market Forecast, 2025-2035 (USD Billion)
Figure 29: Germany Pharmaceutical Excipients Market Forecast, 2025-2035 (USD Billion)
Figure 30: France Pharmaceutical Excipients Market Forecast, 2025-2035 (USD Billion)
Figure 31: UK Pharmaceutical Excipients Market Forecast, 2025-2035 (USD Billion)
Figure 32: Italy Pharmaceutical Excipients Market Forecast, 2025-2035 (USD Billion)
Figure 33: Spain Pharmaceutical Excipients Market Forecast, 2025-2035 (USD Billion)
Figure 34: Rest of Europe Pharmaceutical Excipients Market Forecast, 2025-2035 (USD Billion)
Research Methodology
Related Databooks
March 2026
March 2026
March 2026
March 2026
sales@precedenceresearch.com
+1 804-441-9344
Download Databook
Schedule a Meeting